Ternalys Therapeutics, INC.
At a glance
EmployeesNot reported
In business sinceNot reported
HeadquartersChapel Hill, NC
SAM.gov UEIT7EMGFNJVB53
Ternalys develops proprietary SAGUARO technology for microRNA replacement therapy designed to reverse epigenetic changes in cancer. The company focuses on addressing cancer resistance through epigenetic reprogramming.
Summarized from the company’s own website
Their plant
| Facility | City | State | Employees | Status |
|---|---|---|---|---|
| Ternalys Therapeutics, INC. | Chapel Hill | NC | — | LIKELY ACTIVE |
Compiled from federal records — EPA, OSHA, SAM.gov and the U.S. Census — and from the company’s own website. Federal source data is public domain. Each plant’s page names the source of every field.